80 related articles for article (PubMed ID: 11379819)
1. O-Glycosylation in sprouting neurons in Alzheimer disease, indicating reactive plasticity.
Espinosa B; Zenteno R; Mena R; Robitaille Y; Zenteno E; Guevara J
J Neuropathol Exp Neurol; 2001 May; 60(5):441-8. PubMed ID: 11379819
[TBL] [Abstract][Full Text] [Related]
2. Coexistence of reactive plasticity and neurodegeneration in Alzheimer diseased brains.
Guevara J; Dilhuydy H; Espinosa B; Delacourte A; Quirion R; Mena R; Joanette Y; Zenteno E; Robitaille Y
Histol Histopathol; 2004 Oct; 19(4):1075-84. PubMed ID: 15375749
[TBL] [Abstract][Full Text] [Related]
3. Altered glycosylation pattern of proteins in Alzheimer disease.
Guevara J; Espinosa B; Zenteno E; Vázguez L; Luna J; Perry G; Mena R
J Neuropathol Exp Neurol; 1998 Oct; 57(10):905-14. PubMed ID: 9786241
[TBL] [Abstract][Full Text] [Related]
4. Sialylated and O-glycosidically linked glycans in prion protein deposits in a case of Gerstmann-Sträussler-Scheinker disease.
Zomosa-Signoret V; Mayoral M; Limón D; Espinosa B; Calvillo M; Zenteno E; Martínez V; Guevara J
Neuropathology; 2011 Apr; 31(2):162-9. PubMed ID: 20667006
[TBL] [Abstract][Full Text] [Related]
5. Neuroinflammation induced by amyloid β25-35 modifies mucin-type O-glycosylation in the rat's hippocampus.
Ramos-Martinez I; Martínez-Loustalot P; Lozano L; Issad T; Limón D; Díaz A; Perez-Torres A; Guevara J; Zenteno E
Neuropeptides; 2018 Feb; 67():56-62. PubMed ID: 29174415
[TBL] [Abstract][Full Text] [Related]
6. Characterization of an O-glycosylated plaque-associated protein from Alzheimer disease brain.
Espinosa B; Guevara J; Hernández P; Slomianny MC; Guzmán A; Martínez-Cairo S; Zenteno E
J Neuropathol Exp Neurol; 2003 Jan; 62(1):34-41. PubMed ID: 12528816
[TBL] [Abstract][Full Text] [Related]
7. Monoamine oxidase B is elevated in Alzheimer disease neurons, is associated with γ-secretase and regulates neuronal amyloid β-peptide levels.
Schedin-Weiss S; Inoue M; Hromadkova L; Teranishi Y; Yamamoto NG; Wiehager B; Bogdanovic N; Winblad B; Sandebring-Matton A; Frykman S; Tjernberg LO
Alzheimers Res Ther; 2017 Aug; 9(1):57. PubMed ID: 28764767
[TBL] [Abstract][Full Text] [Related]
8. Intracellular mechanisms of amyloid accumulation and pathogenesis in Alzheimer's disease.
Glabe C
J Mol Neurosci; 2001 Oct; 17(2):137-45. PubMed ID: 11816787
[TBL] [Abstract][Full Text] [Related]
9. Neuronal and microglial involvement in beta-amyloid protein deposition in Alzheimer's disease.
Cras P; Kawai M; Siedlak S; Mulvihill P; Gambetti P; Lowery D; Gonzalez-DeWhitt P; Greenberg B; Perry G
Am J Pathol; 1990 Aug; 137(2):241-6. PubMed ID: 2117395
[TBL] [Abstract][Full Text] [Related]
10. Antibodies to non-beta regions of the beta-amyloid precursor protein detect a subset of senile plaques.
Joachim C; Games D; Morris J; Ward P; Frenkel D; Selkoe D
Am J Pathol; 1991 Feb; 138(2):373-84. PubMed ID: 1704190
[TBL] [Abstract][Full Text] [Related]
11. Apoptotic signals within the basal forebrain cholinergic neurons in Alzheimer's disease.
Wu CK; Thal L; Pizzo D; Hansen L; Masliah E; Geula C
Exp Neurol; 2005 Oct; 195(2):484-96. PubMed ID: 16085017
[TBL] [Abstract][Full Text] [Related]
12. PDAPP; YFP double transgenic mice: a tool to study amyloid-beta associated changes in axonal, dendritic, and synaptic structures.
Brendza RP; O'Brien C; Simmons K; McKeel DW; Bales KR; Paul SM; Olney JW; Sanes JR; Holtzman DM
J Comp Neurol; 2003 Feb; 456(4):375-83. PubMed ID: 12532409
[TBL] [Abstract][Full Text] [Related]
13. α-secretase cleaved amyloid precursor protein (APP) accumulates in cholinergic dystrophic neurites in normal, aged hippocampus.
Yoon SY; Choi JU; Cho MH; Yang KM; Ha H; Chung IJ; Cho GS; Kim DH
Neuropathol Appl Neurobiol; 2013 Dec; 39(7):800-16. PubMed ID: 23414335
[TBL] [Abstract][Full Text] [Related]
14. Distribution of beta/A4 protein and amyloid precursor protein in hereditary cerebral hemorrhage with amyloidosis-Dutch type and Alzheimer's disease.
Rozemuller AJ; Roos RA; Bots GT; Kamphorst W; Eikelenboom P; Van Nostrand WE
Am J Pathol; 1993 May; 142(5):1449-57. PubMed ID: 7684195
[TBL] [Abstract][Full Text] [Related]
15. Differential contributions of recognition factors of two plant lectins -Amaranthus caudatus lectin and Arachis hypogea agglutinin, reacting with Thomsen-Friedenreich disaccharide (Galbeta1-3GalNAcalpha1-Ser/Thr).
Wu AM; Wu JH; Yang Z; Singh T; Goldstein IJ; Sharon N
Biochimie; 2008; 90(11-12):1769-80. PubMed ID: 18809460
[TBL] [Abstract][Full Text] [Related]
16. Early accumulation of heparan sulfate in neurons and in the beta-amyloid protein-containing lesions of Alzheimer's disease and Down's syndrome.
Snow AD; Mar H; Nochlin D; Sekiguchi RT; Kimata K; Koike Y; Wight TN
Am J Pathol; 1990 Nov; 137(5):1253-70. PubMed ID: 2146882
[TBL] [Abstract][Full Text] [Related]
17. Lesion-induced hippocampal plasticity in transgenic Alzheimer's disease mouse models: influences of age, genotype, and estrogen.
Kadish I; van Groen T
J Alzheimers Dis; 2009; 18(2):429-45. PubMed ID: 19584452
[TBL] [Abstract][Full Text] [Related]
18. Early formation of mature amyloid-beta protein deposits in a mutant APP transgenic model depends on levels of Abeta(1-42).
Rockenstein E; Mallory M; Mante M; Sisk A; Masliaha E
J Neurosci Res; 2001 Nov; 66(4):573-82. PubMed ID: 11746377
[TBL] [Abstract][Full Text] [Related]
19. Effects of injected Alzheimer beta-amyloid cores in rat brain.
Frautschy SA; Baird A; Cole GM
Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8362-6. PubMed ID: 1924295
[TBL] [Abstract][Full Text] [Related]
20. Mitochondria and vascular lesions as a central target for the development of Alzheimer's disease and Alzheimer disease-like pathology in transgenic mice.
Aliev G; Seyidova D; Lamb BT; Obrenovich ME; Siedlak SL; Vinters HV; Friedland RP; LaManna JC; Smith MA; Perry G
Neurol Res; 2003 Sep; 25(6):665-74. PubMed ID: 14503022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
